[go: up one dir, main page]

AR122563A1 - Formas cristalinas de ciantraniliprol y proceso de preparación - Google Patents

Formas cristalinas de ciantraniliprol y proceso de preparación

Info

Publication number
AR122563A1
AR122563A1 ARP210101554A ARP210101554A AR122563A1 AR 122563 A1 AR122563 A1 AR 122563A1 AR P210101554 A ARP210101554 A AR P210101554A AR P210101554 A ARP210101554 A AR P210101554A AR 122563 A1 AR122563 A1 AR 122563A1
Authority
AR
Argentina
Prior art keywords
degrees
xrpd pattern
cyantraniliprole
crystalline
peaks
Prior art date
Application number
ARP210101554A
Other languages
English (en)
Inventor
Gal Suez
Hagit Forckosh
Yanai Golub
Jie Lie
Bob Chen
Regev Parnes
Original Assignee
Adama Makhteshim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adama Makhteshim Ltd filed Critical Adama Makhteshim Ltd
Publication of AR122563A1 publication Critical patent/AR122563A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00Arthropodicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Reivindicación 1: Una Forma C de ciantraniliprol cristalina, caracterizada por datos seleccionados de uno o más de los siguientes: un patrón de XRPD que tiene picos a 7,3, 8,2, 8,9, 14,7 y 20,3 grados 2 q ± 0,2 grados 2 q; un patrón de XRPD como se ilustra en la Figura 1. Reivindicación 3: Una Forma D de ciantraniliprol cristalina, caracterizada por datos seleccionados de uno o más de los siguientes: un patrón de XRPD que tiene picos a 6,6, 11,4, 15,7 y 22,4 grados 2 q ± 0,2 grados 2 q; un patrón de XRPD como se ilustra en la Figura 2. Reivindicación 5: Una Forma F de ciantraniliprol cristalina, caracterizada por datos seleccionados de uno o más de los siguientes: un patrón de XRPD que tiene picos a 9,6, 11,3, 18,6, 21,5 y 25,9 grados 2 q ± 0,2 grados 2 q; un patrón de XRPD como se ilustra en la Figura 3. Reivindicación 16: Un proceso de preparación de la forma cristalina de ciantraniliprol de acuerdo con la reivindicación 3 o la reivindicación 4, que comprende someter una solución de 2-[3-bromo-1-(3-cloro-2-piridinil)-1H-pirazol-5-ilo]-6-ciano-8-metilo-4H-3,1-benzoxazin-4-ona en un sistema de disolvente de éter a una reacción de condensación con metilamina seguida de evaporación, secando al vacío para obtener un sólido, en donde dicho sólido se disuelve además en un disolvente de alcohol, seguido por enfriamiento, precipitado, filtrado y secado al vacío para obtener dicha forma en estado sólido de ciantraniliprol.
ARP210101554A 2020-06-08 2021-06-08 Formas cristalinas de ciantraniliprol y proceso de preparación AR122563A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063035865P 2020-06-08 2020-06-08

Publications (1)

Publication Number Publication Date
AR122563A1 true AR122563A1 (es) 2022-09-21

Family

ID=78845357

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP210101554A AR122563A1 (es) 2020-06-08 2021-06-08 Formas cristalinas de ciantraniliprol y proceso de preparación
ARP210101555A AR122564A1 (es) 2020-06-08 2021-06-08 Proceso para la preparación de antranilamidas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP210101555A AR122564A1 (es) 2020-06-08 2021-06-08 Proceso para la preparación de antranilamidas

Country Status (12)

Country Link
US (2) US20230312505A1 (es)
EP (2) EP4165030A4 (es)
CN (2) CN116490492A (es)
AR (2) AR122563A1 (es)
AU (2) AU2021287782A1 (es)
BR (2) BR112022025068A2 (es)
CA (2) CA3181797A1 (es)
CO (2) CO2023000040A2 (es)
IL (2) IL298905A (es)
MX (2) MX2022015596A (es)
PE (2) PE20231426A1 (es)
WO (2) WO2021249396A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113896714A (zh) * 2021-11-23 2022-01-07 江西汇和化工有限公司 一种氯虫苯甲酰胺的合成方法
AR131889A1 (es) * 2023-02-21 2025-05-14 Upl Ltd Un proceso para la preparación de un compuesto de antranilamida e intermedios del mismo
WO2024189625A1 (en) 2023-03-15 2024-09-19 Adama Makhteshim Ltd. Aqueous suspension composition of cyantraniliprole and acetamiprid
CN118812502A (zh) * 2023-04-17 2024-10-22 利尔化学股份有限公司 一种双酰胺类杀虫剂及其中间体的制备方法
WO2025104727A1 (en) 2023-11-16 2025-05-22 Adama Makhteshim Ltd. Solid state forms of cyantraniliprole and uses thereof
CN118146190A (zh) * 2024-02-01 2024-06-07 南开大学 溴氰虫酰胺的新晶型及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN243219B (es) * 2003-01-28 2010-10-01 Du Pont
MY140912A (en) * 2004-07-26 2010-01-29 Du Pont Mixtures of anthranilamide invertebrate pest control agents
TWI363756B (en) * 2004-12-07 2012-05-11 Du Pont Method for preparing n-phenylpyrazole-1-carboxamides
TWI395728B (zh) * 2006-12-06 2013-05-11 Du Pont 製備2-胺基-5-氰基苯甲酸衍生物之方法
BRPI0817168A2 (pt) * 2007-11-08 2015-03-31 Du Pont "método para a preparação de um composto"
CN101550130B (zh) * 2008-04-01 2012-11-07 中国中化股份有限公司 一种制备3-卤代-1-(3-氯-2-吡啶基)-1h-吡唑-5-甲酰卤的方法
RU2500676C2 (ru) * 2008-11-14 2013-12-10 Е.И.Дюпон Де Немур Энд Компани Способ получения негидратируемой кристаллической формы
CN102020633B (zh) * 2009-09-21 2013-08-07 中国中化股份有限公司 一种1-(3,5-二氯吡啶-2-基)-吡唑甲酰胺类化合物的制备方法
CN110028489B (zh) * 2018-01-12 2021-08-06 沈阳中化农药化工研发有限公司 一种减压法制备苯甲酰胺类化合物的方法
WO2019207595A1 (en) * 2018-04-23 2019-10-31 Natco Pharma Limited An improved process for the preparation of anthranilamide derivatives
CN112552284B (zh) * 2020-12-18 2022-08-12 重庆华歌生物化学有限公司 一种氯虫苯甲酰胺的制备方法

Also Published As

Publication number Publication date
WO2021249396A1 (en) 2021-12-16
EP4165030A4 (en) 2024-07-31
MX2022015597A (es) 2023-02-01
EP4165030A1 (en) 2023-04-19
MX2022015596A (es) 2023-02-01
IL298905A (en) 2023-02-01
AU2021287782A1 (en) 2023-02-02
BR112022025066A2 (pt) 2023-03-07
CA3181797A1 (en) 2021-12-16
CN116490491A (zh) 2023-07-25
CA3181785A1 (en) 2021-12-16
BR112022025068A2 (pt) 2023-03-07
CO2023000040A2 (es) 2023-03-27
US20230348414A1 (en) 2023-11-02
EP4165031A1 (en) 2023-04-19
PE20231426A1 (es) 2023-09-13
CN116490492A (zh) 2023-07-25
US20230312505A1 (en) 2023-10-05
WO2021249395A1 (en) 2021-12-16
EP4165031A4 (en) 2024-09-25
AR122564A1 (es) 2022-09-21
AU2021286610A1 (en) 2023-01-19
PE20231381A1 (es) 2023-09-07
IL298908A (en) 2023-02-01
CO2023000039A2 (es) 2023-03-27

Similar Documents

Publication Publication Date Title
AR122563A1 (es) Formas cristalinas de ciantraniliprol y proceso de preparación
El‐Sepelgy et al. Brønsted Acid Catalyzed, Conjugate Addition of β‐Dicarbonyls to In Situ Generated ortho‐Quinone Methides—Enantioselective Synthesis of 4‐Aryl‐4H‐Chromenes
Hu et al. Copper-catalyzed tandem oxidative synthesis of quinazolinones from 2-aminobenzonitriles and benzyl alcohols
RU2014136174A (ru) Способ получения цеолитного материала
AR116537A1 (es) Método para preparar compuestos de uracilo que contienen isoxazolina mediante metilación
CN106086123B (zh) 一种应用离子液体提高黄酮类化合物水溶性的方法
Song et al. A cascade Claisen rearrangement/o-quinone methide formation/electrocyclization approach to 2 H-chromenes
Reddy et al. Silica gel-supported tungstic acid (STA): A new, highly efficient and recyclable catalyst for the synthesis of 1H-pyrazolo [1, 2-b] phthalazine-5, 10-dione carbonitriles and carboxylates under neat conditions
PL402863A1 (pl) Pochodne 1-arylo-6-benzenosulfonyloimidazo [1,2-a][1.3.5] triazyny oraz sposób ich otrzymywania
WO2017146457A3 (ko) 열전환 폴리(벤즈옥사졸-이미드) 공중합체 기반의 초박형 복합막 및 그 제조방법
Chadha et al. Green methods mediated synthesis of chromene derivatives using magnetic nanoparticles as heterogeneous and reusable nanocatalyst: A review
Kalita et al. Ni–Al2O3 as reusable heterogeneous catalyst for expedient one-pot synthesis of naphthopyrans
Lee et al. Highly enantioselective catalytic 1, 3-dipolar cycloadditions of α-alkyl diazoacetates: efficient synthesis of functionalized 2-pyrazolines
Alinezhad et al. Protic pyridinium ionic liquid: As an efficient, green and environmentally friendly catalyst for the one-pot synthesis of amidoalkyl naphthol derivatives
Feng et al. Regioselective synthesis of functionalized [1, 8] naphthyridine derivatives via three-component domino reaction under catalyst-free conditions
Cui et al. Concise and Stereodivergent Approach to Chromanone Lactones through Copper‐Catalyzed Asymmetric Vinylogous Addition of Siloxyfurans to 2‐Ester‐Substituted Chromones
Dindulkar et al. Supported ceric ammonium nitrate: A highly efficient catalytic system for the synthesis of diversified 2, 3-substituted 2, 3-dihydroquinazolin-4 (1H)-ones
Ma et al. Sulfonation of carbonized xylan-type hemicellulose: a renewable and effective biomass-based biocatalyst for the synthesis of O-and N-heterocycles
An et al. Asymmetric domino double Michael addition of nitroolefins and aldehyde esters with trans-perhydroindolic acid as an organocatalyst
HRP20160414T1 (hr) Postupak sinteze derivata 3,6-dihidro-1,3,5-triazina
CN103193753A (zh) 一种酸性离子液体催化制备氧杂蒽二酮类衍生物的方法
RU2014143721A (ru) Гидрат циклопептидного соединения, способ его получения и его применение
CN103193716B (zh) 一种酸性离子液体催化制备3,4-二氢嘧啶-2(1h)-酮衍生物的方法
AR124966A1 (es) Un proceso para la preparación de sulfentrazona con compatibilidad con mezcla en tanque
Kim et al. Concise Asymmetric Total Synthesis of ent‐Ancistrocladinium A